National Health (Highly specialised drugs program) Special Arrangement Amendment Instrument 2019 (No. 5) (PB 39 of 2019) (Cth)

Case

PB 39 of 2019

National Health (Highly specialised drugs program) Special Arrangement Amendment Instrument 2019 (No. 5)

National Health Act 1953

___________________________________________________________________________

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsection 100(2) of the National Health Act 1953.

Dated            24 May       2019

BEN SLADIC

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

  1. Name of Instrument

(1)This Instrument is the National Health (Highly specialised drugs program) Special Arrangement Amendment Instrument 2019 (No. 5).

(2)This Instrument may also be cited as PB 39 of 2019.

  1. Commencement

This Instrument commences on 1 June 2019.

  1. Amendment of National Health (Highly specialised drugs program) Special Arrangement 2010 (PB 116 of 2010)

Schedule 1 amends the National Health (Highly specialised drugs program) Special Arrangement 2010 (PB 116 of 2010).

Schedule 1       Amendments

  1. Schedule 1, entry for Entecavir in the form Tablet 0.5 mg (as monohydrate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

ENTECAVIR APO GX EMP C4993 C5036 60 5 D
  1. Schedule 1, entry for Entecavir in the form Tablet 1 mg (as monohydrate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

ENTECAVIR APO GX EMP C5037 C5044 60 5 D
  1. Schedule 1, entry for Filgrastim

(a)omit:

Injection 300 micrograms in 0.5 mL single use pre-filled syringe (TevaGrastim) Injection TevaGrastim TB EMP C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 20 11 D

(b)omit:

Injection 480 micrograms in 0.8 mL single use pre-filled syringe (TevaGrastim) Injection TevaGrastim TB EMP C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 20 11 D
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0